bioMérieux S.A. (OTCMKTS:BMXMF – Get Rating) reached a new 52-week low during trading on Thursday . The stock traded as low as $87.13 and last traded at $88.15, with a volume of 103 shares traded. The stock had previously closed at $91.50.
Separately, Zacks Investment Research upgraded bioMérieux from a “sell” rating to a “hold” rating in a report on Friday, May 6th.
The stock’s 50-day moving average price is $101.33 and its 200-day moving average price is $117.28. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.65 and a current ratio of 2.31.
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors.
See Also
- Get a free copy of the StockNews.com research report on bioMérieux (BMXMF)
- Carvana Insiders Buy Shares But Maybe You Shouldn’t
- Dutch Bros Gets Scalded By Inflation
- The S&P 500 Could Fall Another 28%
- Corning Stock is a Technology Value Play
- Anheuser-Busch InBev May Need One More Quarter to Confirm a Buy Signal
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
